Recap of JFR 2023 with iCAD in Paris
intellimed and iCAD team
intellimed was privileged to participate alongsideiCAD at the JFR (Journées Francophones de Radiologie) 2023 in Paris, France, where we witnessed revolutionary advances in AI-powered healthcare solutions. iCAD presented its ProFound AI Breast Health, reaffirming its commitment to revolutionizing cancer detection and improving patient outcomes.
Highlights of JFR 2023
Innovation in Cancer Detection:
Demonstrations ofiCAD showcased theProFound AI Breast Health suite, highlighting its ability to detect breast cancer earlier and more accurately. The suite introduces new AI-powered features eagerly awaited by radiologists, promising to significantly improve diagnostic capabilities.
The conference provided an excellent platform for networking and collaboration. intellimed engaged in fruitful discussions with iCAD and other partners, exploring how AI solutions such as ProFound AI can be integrated into everyday clinical practices for the benefit of patients worldwide.
JFR 2023 highlighted promising developments that point to a future where AI plays a key role in personalized medicine and healthcare innovation. The commitment ofiCAD s commitment to improving diagnostic accuracy and efficiency underlines their mission to create a world where cancer cannot hide.
Our Perspective: Partnership for Progress
At intellimed, we're excited about the possibilities offered by AI-powered technologies in healthcare. Our partnership with iCAD at JFR 2023 demonstrated our shared commitment to harnessing innovation for better patient outcomes. We are particularly impressed by the way ProFound AI is redefining the mammography landscape and beyond, providing clinicians with powerful tools to make informed decisions and improve diagnostic workflows.
Conclusion
JFR 2023 was not only a showcase for technological innovation, but also a testament to the collaborative efforts that drive advances in healthcare. As partners, intellimed and iCAD are leading the way to a future where AI improves medical practice, enables clinicians to do better, and ultimately improves the lives of patients worldwide.
For more information about our experience at JFR 2023 and to find out how AI-powered solutions are transforming healthcare, visit our website or contact us directly. Together, we can continue to push the boundaries of medical excellence and innovation.
iCAD
iCAD is a company that provides software solutions for medical image processing. One of their flagship products is ProFound AI, AI-based software designed to analyze mammography images. ProFound AI aids breast cancer screening and diagnosis by using AI-based detection technology to identify potential abnormalities in mammography images, helping radiologists to make more accurate initial assessments and facilitating faster review and decision-making processes. www.icadmed.com/